Division Deputy Director
Gastroenterology and Inborn Errors Products
Food and Drug Administration
Andrew is currently the Division Deputy Director of Gastroenterology and Inborn Errors Products, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA) since 2010. Before joining FDA, Andrew has served as Portfolio Leader in Established Products responsible for providing worldwide leadership in support of GI and diverse Internal Medicine products within the Established Products Therapeutic Area of Johnson and Johnson Pharmaceutical Research and Development of Johnson and Johnson from 2000-2010. He has served as Attending Physician in Gastroenterology and Hepatology at Children’s Hospital of Philadelphia from 1993-2010. Andrew is a graduate of Columbia College of Columbia University and of the Mount Sinai School of Medicine. He completed his residency in Pediatrics at the Children’s Hospital of Philadelphia followed by a Pediatric Gastroenterology Clinical Fellowship and a Post-Doctoral Fellowship in Cellular and Molecular Physiology at New England Medical Center. Andrew is Adjunct Professor of Pediatrics at the University of Maryland School of Medicine ,Adjunct Associate Professor of Pediatrics in the University of Pennsylvania School of Medicine and Associate Professor of Pharmacy at the University of the Sciences in Philadelphia. He has served as Principal Editor of Pediatric Drug Development: Concepts and Applications published April 2009 with Wiley-Blackwell and now in its 2nd edition released August 19, 2013. He is a member of multiple professional medical societies including Alpha Omega Alpha Honor Medical Society, American Gastroenterological Association and the North American Society for Pediatric Gastroenterology and Nutrition.